We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current ESLA market cap is 47.41M. The company's latest EPS is USD -0.2020 and P/E is -6.44.
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | |||
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -150k | -169k | 0 | -470k | -3.95M |
Net Income | -63k | -76k | 139k | -470k | -3.95M |
Year End June 29 2024 | 2021 | 2022 | 2024 |
---|---|---|---|
USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 |
Operating Income | -249k | -1.57M | -7.31M |
Net Income | -248k | -996k | -7.31M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | |||
Total Assets | 9.78M | 9.92M | 27.35M | 8.63M | 4.45M |
Total Liabilities | 2.77M | 2.99M | 17.28M | 138k | 181k |
Total Equity | -2.53M | -2.82M | 10.07M | 8.5M | 4.27M |
Year End June 29 2024 | 2021 | 2022 | 2024 |
---|---|---|---|
USD ($) | USD ($) | USD ($) | |
Total Assets | 45.8M | 9.72M | 4.45M |
Total Liabilities | 1.62M | 2.65M | 181k |
Total Equity | -1.01M | -2.26M | 4.27M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | |||
Operating | -276k | -488k | N/A | -15.78M | -16.07M |
Investing | 77k | 99k | N/A | 4.96M | 4.96M |
Financing | 187k | 383k | N/A | 13.06M | 12.79M |
Year End June 29 2024 | 2021 | 2022 | 2024 |
---|---|---|---|
USD ($) | USD ($) | USD ($) | |
Operating | -316k | -1.04M | -16.07M |
Investing | -45.19M | 36.17M | 4.96M |
Financing | 45.98M | -35.56M | 12.79M |
Market Cap | 47.41M |
Price to Earnings Ratio | -6.44 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 11.29 |
Price to Book Ratio | 11.01 |
Dividend Yield | - |
Shares Outstanding | 36.19M |
Average Volume (1 week) | 33.84k |
Average Volume (1 Month) | 20.49k |
52 Week Change | -16.03% |
52 Week High | 3.23 |
52 Week Low | 0.63 |
Spread (Intraday) | 0.07 (5.07%) |
Company Name | Estrella Immunopharma Inc |
Address |
108 w. 13th street wilmington, delaware 19801 |
Website | https:// |
Industry | blank checks (6770) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions